Pioglitazone to Treat Opioid Withdrawal Symptoms
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01517165|
Recruitment Status : Terminated
First Posted : January 25, 2012
Last Update Posted : April 5, 2018
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute on Drug Abuse (NIDA) )
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Terminated|
|Actual Primary Completion Date :||February 2, 2015|
|Actual Study Completion Date :||February 2, 2015|
Alvarez RP, Chen G, Bodurka J, Kaplan R, Grillon C. Phasic and sustained fear in humans elicits distinct patterns of brain activity. Neuroimage. 2011 Mar 1;55(1):389-400. doi: 10.1016/j.neuroimage.2010.11.057. Epub 2010 Nov 25.
Back SE, Hartwell K, DeSantis SM, Saladin M, McRae-Clark AL, Price KL, Moran-Santa Maria MM, Baker NL, Spratt E, Kreek MJ, Brady KT. Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend. 2010 Jan 1;106(1):21-7. doi: 10.1016/j.drugalcdep.2009.07.016. Epub 2009 Sep 2.